Table 3.
Genea | Position | rs No. | Risk Alleleb | RAF in Controlsc (n = 781) | Cases With Colorectal Polyps |
P for Comparison Between Case Groups |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenomas Only (n = 489) |
Serrated Polyps Only (n = 401) |
Adenomas + Serrated Polyps (n = 188) |
||||||||||||||
RAF | ORd | 95% CI | RAF | ORd | 95% CI | RAF | ORd | 95% CI | ADs vs. SPs | ADs vs. ADs + SPs | SPs vs. ADs + SPs | |||||
DUSP10 | 1q41 | rs6691170 | T | 0.36 | 0.33 | 0.89 | 0.75, 1.05 | 0.34 | 0.89 | 0.74, 1.08 | 0.34 | 0.92 | 0.73, 1.18 | 0.96 | 0.76 | 0.80 |
MYNN | 3q26.2 | rs10936599 | C | 0.73 | 0.76 | 1.18 | 0.98, 1.42 | 0.74 | 0.99 | 0.81, 1.20 | 0.78 | 1.27 | 0.98, 1.67 | 0.11 | 0.57 | 0.08 |
EIF3H | 8q23.3 | rs16892766 | C | 0.08 | 0.08 | 1.01 | 0.75, 1.36 | 0.08 | 1.01 | 0.73, 1.40 | 0.09 | 1.14 | 0.77, 1.70 | 0.99 | 0.58 | 0.59 |
MYC | 8q24 | rs6983267 | G | 0.53 | 0.50 | 0.93 | 0.79, 1.09 | 0.49 | 0.91 | 0.76, 1.09 | 0.53 | 1.03 | 0.82, 1.29 | 0.85 | 0.39 | 0.33 |
10p14e | rs10795668 | G | 0.68 | 0.70 | 1.14 | 0.96, 1.36 | 0.69 | 1.09 | 0.90, 1.33 | 0.69 | 1.06 | 0.83, 1.36 | 0.69 | 0.59 | 0.84 | |
11q23.1e | rs3802842 | C | 0.29 | 0.31 | 1.08 | 0.91, 1.28 | 0.26 | 0.86 | 0.71, 1.05 | 0.28 | 0.95 | 0.74, 1.21 | 0.03 | 0.32 | 0.50 | |
DIP2B | 12q13.13 | rs11169552 | C | 0.71 | 0.73 | 1.12 | 0.94, 1.34 | 0.73 | 1.10 | 0.90, 1.34 | 0.73 | 1.11 | 0.86, 1.42 | 0.85 | 0.93 | 0.95 |
BMP4 | 14q22.2 | rs4444235 | C | 0.49 | 0.45 | 0.87 | 0.74, 1.02 | 0.49 | 1.03 | 0.86, 1.23 | 0.47 | 0.94 | 0.75, 1.18 | 0.09 | 0.52 | 0.48 |
CRAC1/GREM1 | 15q13.3 | rs4779584 | T | 0.23 | 0.24 | 1.06 | 0.88, 1.28 | 0.22 | 1.01 | 0.82, 1.39 | 0.24 | 1.07 | 0.82, 1.38 | 0.67 | 0.99 | 0.72 |
CDH1 | 16q22.1 | rs9929218 | G | 0.71 | 0.75 | 1.24 | 1.04, 1.50 | 0.70 | 1.00 | 0.82, 1.21 | 0.74 | 1.23 | 0.95, 1.60 | 0.05 | 0.94 | 0.15 |
SMAD7 | 18q21.1 | rs4939827 | T | 0.50 | 0.52 | 1.09 | 0.93, 1.29 | 0.49 | 0.93 | 0.76, 1.11 | 0.52 | 1.09 | 0.86, 1.37 | 0.10 | 0.97 | 0.22 |
RHPN2 | 19q13.1 | rs10411210 | C | 0.89 | 0.90 | 1.14 | 0.87, 1.49 | 0.89 | 1.02 | 0.77, 1.36 | 0.89 | 1.01 | 0.70, 1.45 | 0.49 | 0.53 | 0.95 |
BMP2 | 20p12.3 | rs961253 | A | 0.32 | 0.37 | 1.23 | 1.03, 1.46 | 0.38 | 1.24 | 1.03, 1.50 | 0.36 | 1.16 | 0.92, 1.48 | 0.90 | 0.67 | 0.61 |
Risk-allele scoref | NA | NA | NA | NA | 1.07 | 1.01, 1.13 | NA | 1.00 | 0.94, 1.06 | NA | 1.07 | 0.99, 1.15 | 0.03 | 0.97 | 0.09 |
Abbreviations: AD, adenoma; CI, confidence interval; GWAS, genome-wide association studies; NA, not applicable; OR, odds ratio; RAF, risk allele frequency; rs, reference SNP; SNP, single-nucleotide polymorphism; SP, serrated polyp.
a For gene abbreviations, see Table 1.
b Allele associated with an increased risk of colorectal cancer in prior GWAS.
c Reference category (OR = 1).
d Odds per risk-allele increase; adjusted for study phase, age, race/ethnicity, and sex.
e No known gene association with this locus.
f Combined number of risk alleles across all SNPs in Table 3; possible values range from 0 to 26.